Reviewing Amentum (AMTM) and Its Rivals

Amentum (NYSE:AMTM – Get Free Report) is one of 25 publicly-traded companies in the “ENGINRG/R&D SVS” industry, but how does it weigh in compared to its competitors? We will compare Amentum to related businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Analyst Recommendations This is a […]

Leave a Reply

Your email address will not be published.

Previous post Zacks Research Issues Negative Forecast for Neogen Earnings
Next post Manhattan Associates, Inc. $MANH Shares Bought by Raymond James Financial Inc.